ES2386317T3 - Genes expresados diferencialmente en cáncer de mama - Google Patents

Genes expresados diferencialmente en cáncer de mama Download PDF

Info

Publication number
ES2386317T3
ES2386317T3 ES08010460T ES08010460T ES2386317T3 ES 2386317 T3 ES2386317 T3 ES 2386317T3 ES 08010460 T ES08010460 T ES 08010460T ES 08010460 T ES08010460 T ES 08010460T ES 2386317 T3 ES2386317 T3 ES 2386317T3
Authority
ES
Spain
Prior art keywords
seq
metastatic
amino acids
polypeptide
polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES08010460T
Other languages
English (en)
Spanish (es)
Inventor
Joerg Kaufmann
Greg Harrowe
Cristoph Reinhard
Sanmao Kang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Novartis Vaccines and Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines and Diagnostics Inc filed Critical Novartis Vaccines and Diagnostics Inc
Application granted granted Critical
Publication of ES2386317T3 publication Critical patent/ES2386317T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES08010460T 2000-01-10 2001-01-09 Genes expresados diferencialmente en cáncer de mama Expired - Lifetime ES2386317T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17546200P 2000-01-10 2000-01-10
US175462P 2000-01-10

Publications (1)

Publication Number Publication Date
ES2386317T3 true ES2386317T3 (es) 2012-08-17

Family

ID=22640304

Family Applications (2)

Application Number Title Priority Date Filing Date
ES08010460T Expired - Lifetime ES2386317T3 (es) 2000-01-10 2001-01-09 Genes expresados diferencialmente en cáncer de mama
ES01942365T Expired - Lifetime ES2311016T3 (es) 2000-01-10 2001-01-09 Genes expresados diferencialmente en cancer de mama.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES01942365T Expired - Lifetime ES2311016T3 (es) 2000-01-10 2001-01-09 Genes expresados diferencialmente en cancer de mama.

Country Status (9)

Country Link
US (1) US7605246B2 (https=)
EP (2) EP1985701B1 (https=)
JP (2) JP5250168B2 (https=)
AT (1) ATE402258T1 (https=)
AU (1) AU2001229367A1 (https=)
DE (1) DE60134956D1 (https=)
ES (2) ES2386317T3 (https=)
PT (1) PT1248841E (https=)
WO (1) WO2001051515A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081517B2 (en) * 2000-01-10 2006-07-25 Chiron Corporation Genes differentially expressed in breast cancer
DE102011110592A1 (de) 2011-08-18 2013-02-21 Rena Gmbh Verfahren zum Konditionieren von flachen Gegenständen
CN112837822B (zh) * 2020-09-24 2023-05-02 广州市疾病预防控制中心(广州市卫生检验中心、广州市食品安全风险监测与评估中心、广州医科大学公共卫生研究院) 预测covid-19患者发生轻至重度进展的标志物及试剂盒和建立方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
EP0127839B1 (en) 1983-05-27 1992-07-15 THE TEXAS A&M UNIVERSITY SYSTEM Method for producing a recombinant baculovirus expression vector
US4745051A (en) 1983-05-27 1988-05-17 The Texas A&M University System Method for producing a recombinant baculovirus expression vector
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
ZA848495B (en) 1984-01-31 1985-09-25 Idaho Res Found Production of polypeptides in insect cells
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
IL77186A0 (en) 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
GB2189699A (en) 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
GB8610600D0 (en) 1986-04-30 1986-06-04 Novo Industri As Transformation of trichoderma
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
ATE135397T1 (de) 1988-09-23 1996-03-15 Cetus Oncology Corp Zellenzuchtmedium für erhöhtes zellenwachstum, zur erhöhung der langlebigkeit und expression der produkte
FR2649120B1 (fr) 1989-06-30 1994-01-28 Cayla Nouvelle souche et ses mutants de champignons filamenteux, procede de production de proteines recombinantes a l'aide de ladite souche et souches et proteines obtenues selon ce procede
WO1991016116A1 (en) 1990-04-23 1991-10-31 Cellpro Incorporated Immunoselection device and method
US5641670A (en) 1991-11-05 1997-06-24 Transkaryotic Therapies, Inc. Protein production and protein delivery
CA2121038C (en) 1992-08-13 2002-05-14 Akiya Yamada Oral preparation for release in lower digestive tracts
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
CA2388922A1 (en) * 1999-11-19 2001-05-25 Human Genome Sciences, Inc. 23 human secreted proteins

Also Published As

Publication number Publication date
ATE402258T1 (de) 2008-08-15
US7605246B2 (en) 2009-10-20
DE60134956D1 (de) 2008-09-04
ES2311016T3 (es) 2009-02-01
PT1248841E (pt) 2008-09-15
EP1248841B1 (en) 2008-07-23
US20020004239A1 (en) 2002-01-10
WO2001051515A2 (en) 2001-07-19
JP2012143242A (ja) 2012-08-02
WO2001051515A3 (en) 2002-01-24
EP1248841A2 (en) 2002-10-16
JP2003519480A (ja) 2003-06-24
EP1985701A2 (en) 2008-10-29
AU2001229367A1 (en) 2001-07-24
EP1985701B1 (en) 2012-05-30
JP5250168B2 (ja) 2013-07-31
EP1985701A3 (en) 2009-01-07
HK1118861A1 (en) 2009-02-20

Similar Documents

Publication Publication Date Title
US20020051990A1 (en) Novel gene targets and ligands that bind thereto for treatment and diagnosis of ovarian carcinomas
WO2003083074A2 (en) Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
US7442520B2 (en) Gene BRCC-3 and diagnostic and therapeutic uses thereof
US7253272B2 (en) Gene BRCC-2 and diagnostic and therapeutic uses thereof
US20040082771A1 (en) Anti-apoptopic gene SCC-S2 and diagnostic and therapeutic uses thereof
ES2344179T3 (es) Genes expresados diferencialmente en cancer pancreatico y displasia.
ES2395103T3 (es) Variantes de Scratch asociados al cáncer
US20030228317A1 (en) Gene BRCC-1 and diagnostic and therapeutic uses thereof
US7138512B2 (en) Gene SHINC-2 and diagnostic and therapeutic uses thereof
ES2386317T3 (es) Genes expresados diferencialmente en cáncer de mama
US9134314B2 (en) Methods for diagnosing and treating cancers
US20130196314A1 (en) Genes Differentially Expressed in Breast Cancer
US20040161775A1 (en) Gene SHINC-1 and diagnostic and therapeutic uses thereof
JP2003519480A5 (https=)
US20020061552A1 (en) Mammalian dishevelled-associated proteins
HK1118861B (en) Genes differentially expressed in breast cancer
ES2303595T3 (es) Moleculas marcadoras asociadas con tumores pulmonares.
US20060089493A1 (en) Novel gene targets and ligands that bind thereto for treatment and diagnosis of colon carcinomas
US20030186232A1 (en) Human and non-human primate homologues of Nkd protein, nucleic acid sequences encoding, and uses thereof